Eliem Therapeutics, Inc. (ELYM) has a market capitalization of $342.68M and trades at $5.11. The 52-week range is 2.35-11.55.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -5.8, Earnings Per Share (EPS) of $-0.88.
The stock has a beta of -0.38, operates in the Healthcare sector.
